Innohale Therapeutics is transforminig inhaled Nitric Oxide therapy and offering an enabling technology for home care that is both scalable and cost effective.
Despite being an established therapy, inhaled nitric oxide (iNO) is still only accessible to 10% of patients, mainly in ICUs. This is due to its high cost, complex monitorning technology, and cumbersome delivery logistics via pressurized NO tanks.
Our vision is to make this potent therapy accessible to all patients, everywhere.
Our proprietary technology delivers on-demand NO via bedside, portable, reliable and cost-efficient NO delivery systems that include remote monitoring and automated dosing. This technology enables NO therapy expansion into areas of unmet needs in the hospitals and at home (where it is not accessible today), with superior precision, quality, safety and affordability.